Connecture Reports Financial Results for Third Quarter 2016
Nov 07, 2016 21:06 pm UTC| Business
BROOKFIELD, Wis., Nov. 07, 2016 -- Connecture, Inc.(Nasdaq:CNXR), a provider of web-based information systems used to create health insurance marketplaces, today announced financial results for the quarter ended...
Portola Pharmaceuticals Reports Third Quarter 2016 Financial Results and Provides Corporate Update
Nov 07, 2016 21:05 pm UTC| Business
SOUTH SAN FRANCISCO, Calif., Nov. 07, 2016 -- Portola Pharmaceuticals, Inc.® (NASDAQ:PTLA) today provided a corporate update and reported its financial results for the third quarter ended September 30, 2016. “We...
Ultragenyx Reports Third Quarter 2016 Financial Results and Corporate Update
Nov 07, 2016 21:05 pm UTC| Business
NOVATO, Calif., Nov. 07, 2016 -- Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE), a biopharmaceutical company focused on the development of novel products for rare and ultra-rare diseases, today reported its financial...
Kura Oncology Reports Third Quarter 2016 Financial Results
Nov 07, 2016 21:05 pm UTC| Business
LA JOLLA, Calif., Nov. 07, 2016 -- Kura Oncology, Inc., (Nasdaq:KURA) a clinical stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer, today reported...
YRC Worldwide to Present at Stephens Fall Investment Conference
Nov 07, 2016 21:05 pm UTC| Business
OVERLAND PARK, Kan., Nov. 07, 2016 -- YRC Worldwide Inc. (NASDAQ:YRCW) today announced that James Welch, Chief Executive Officer and Jamie Pierson, Chief Financial Officer will deliver a company presentation at 9:00...
Stereotaxis Reports 2016 Third Quarter Financial Results
Nov 07, 2016 21:05 pm UTC| Business
Completed $24 million private placement equity financingRetired all outstanding debt at significant discountAppointed three board members with extensive medical device experienceShipped fifth Niobe® ES system to JapanGrew...
Nivalis Therapeutics Reports Third Quarter 2016 Financial Results
Nov 07, 2016 21:05 pm UTC| Business
BOULDER, Colo., Nov. 07, 2016 -- Nivalis Therapeutics, Inc. (NASDAQ:NVLS),a clinical-stage pharmaceutical company focused on treating people with cystic fibrosis (CF), today reported financial results and recent...